Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prognostic Value of Hyperpolarized 13C MRI for Clinical Myocardial Viability — Stella

Home/Coronary Artery Disease/

View on ClinicalTrials.gov

Recruiting

Back to Coronary Artery Disease trials

Trial locations(1 site)

United States

University of Texas Southwestern Medical Center, Dallas, Texas

Key details

Sponsor

University of Texas Southwestern Medical Center

Collaborators

American Heart Association

Enrollment target

~30 participants

Started

June 2023

Primary completion

June 2026

Age range

20 Years – 80 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.